The Council of Scientific and Industrial Research under its New Millennium Indian Technology Leadership Initiative scheme has approved the implementation of the project “Customized adaptation of nonClonableID technology to establish authenticity of medical products” by Pune-based Bilcare Ltd.
Dr Praful Naik, Executive Director & Chief Scientific Officer, Bilcare, has been designated the principal investigator for the project.
With counterfeit drugs posing a major challenge in the pharmaceutical space, product accountability and traceability is critical for providing quality medical products. The issue covers not only detecting counterfeits or eliminating illegal duplicates, but also ensuring that medicine of genuine origin is consumed by the patients.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.